Abstract:Background Growing evidence suggests that cancer stem cells (CSCs) are responsible for cancer initiation in tumors. Bach1 has been identified to contribute to several tumor progression, including lung cancer. The role of Bach1 in CSCs remains poorly known. Therefore, the function of Bach1 on lung CSCs was focused currently. Methods The expression of Bach1, CD133, CD44, Sox2, Nanog and Oct4 mRNA was assessed using Real-Time Quantitative Reverse Transcription PCR (RT-qPCR). Protein expression of Bach1, CD133, CD44, Sox2, Nanog, Oct4, p53, BCL2, BAX, p-p38, p-AKT1, c-Fos and c-Jun protein was analyzed by western blotting. 5-ethynyl-29-deoxyuridine (EdU), colony formation, Flow cytometry analysis and transwell invasion assay were carried out to analyze lung cancer cell proliferation, apoptosis and invasion respectively. Tumor sphere formation assay was utilized to evaluate spheroid capacity. Flow cytometry analysis was carried out to isolate CD133 or CD44 positive lung cancer cells. The relationship between Bach1 and CD44 was verified using ChIP-qPCR and dual-luciferase reporter assay. Xenograft tumor tissues were collected for hematoxylin and eosin (HE) staining and IHC analysis to evaluate histology and Ki-67. Results The ratio of CD44 + CSCs from A549 and SPC-A1 cells were significantly enriched. Tumor growth of CD44 + CSCs was obviously suppressed in vivo compared to CD44− CSCs. Bach1 expression was obviously increased in CD44 + CSCs. Then, via using the in vitro experiment, it was observed that CSCs proliferation and invasion were greatly reduced by the down-regulation of Bach1 while cell apoptosis was triggered by knockdown of Bach1. Loss of Bach1 was able to repress tumor-sphere formation and tumor-initiating CSC markers. A repression of CSCs growth and metastasis of shRNA-Bach1 was confirmed using xenograft models and caudal vein injection. The direct interaction between Bach1 and CD44 was confirmed by ChIP-qPCR and dual-luciferase reporter assay. Furthermore, mitogen-activated protein kinases (MAPK) signaling pathway was selected and we proved the effects of Bach1 on lung CSCs were associated with the activation of the MAPK pathway. As manifested, loss of Bach1 was able to repress p-p38, p-AKT1, c-Fos, c-Jun protein levels in lung CSCs. Inhibition of MAPK signaling remarkably restrained lung CSCs growth and CSCs properties induced by Bach1 overexpression. Conclusion In summary, we imply that Bach1 demonstrates great potential for the treatment of lung cancer metastasis and recurrence via activating CD44 and MPAK signaling.

Bach1: Function, Regulation, and Involvement in Disease

Pathophysiological role of BACH transcription factors in digestive system diseases

Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy

Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.

Bach1-induced Suppression of Angiogenesis is Dependent on the BTB Domain

Roles of transcription factor Bach1 in human microvascular endothelial cell function

Bach1 Induces Endothelial Cell Apoptosis and Cell-Cycle Arrest Through ROS Generation.

The Critical Role of Bach2 in Shaping the Balance Between CD4+ T Cell Subsets in Immune-Mediated Diseases

Uncovering BTB and CNC Homology1 (BACH1) as a Novel Cancer Therapeutic Target

BACH1 deficiency prevents neointima formation and maintains the differentiated phenotype of vascular smooth muscle cells by regulating chromatin accessibility

BTB and CNC Homology 1 (bach1) Induces Lung Cancer Stem Cell Phenotypes by Stimulating CD44 Expression.

Bach1 regulates self-renewal and impedes mesendodermal differentiation of human embryonic stem cells.

The role of Bach2 in regulating CD8 + T cell development and function

BTB and CNC Homology 1 (bach1) Promotes Human Ovarian Cancer Cell Metastasis by HMGA2-mediated Epithelial-Mesenchymal Transition

Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis.

Bach2: A Key Regulator in Th2-Related Immune Cells and Th2 Immune Response

Bach1 promotes muscle regeneration through repressing Smad-mediated inhibition of myoblast differentiation

Protections of Transcription Factor BACH2 and Natural Product Myricetin Against Pathological Cardiac Hypertrophy and Dysfunction

Diverging Regulation of Bach2 Protein and RNA Expression Determine Cell Fate in Early B Cell Response

BACH1 Controls Hepatic Insulin Signaling and Glucose Homeostasis in Mice

BACH2: The Future of Induced T-Regulatory Cell Therapies